Private Advisor Group LLC Increases Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Private Advisor Group LLC grew its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 82.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,926 shares of the company's stock after purchasing an additional 3,572 shares during the quarter. Private Advisor Group LLC's holdings in HCA Healthcare were worth $2,739,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of HCA. Atwood & Palmer Inc. bought a new stake in HCA Healthcare in the first quarter valued at $28,000. Bartlett & CO. Wealth Management LLC increased its stake in HCA Healthcare by 888.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after purchasing an additional 80 shares in the last quarter. ORG Partners LLC raised its holdings in HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after buying an additional 86 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. raised its holdings in HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after buying an additional 50 shares during the last quarter. Finally, Legacy Investment Solutions LLC raised its holdings in HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after buying an additional 95 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Activity

In other news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer owned 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.30% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on HCA shares. Royal Bank Of Canada restated an "outperform" rating and set a $404.00 price objective (up previously from $376.00) on shares of HCA Healthcare in a report on Monday, June 23rd. Morgan Stanley set a $410.00 price objective on shares of HCA Healthcare and gave the stock an "equal weight" rating in a report on Monday, June 9th. Truist Financial raised their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a report on Wednesday, July 16th. Bank of America downgraded shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 target price for the company. in a research note on Wednesday, July 16th. Finally, Barclays set a $416.00 target price on shares of HCA Healthcare and gave the stock an "overweight" rating in a research note on Monday, June 2nd. Eight investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $399.46.

HCA Healthcare Price Performance

NYSE:HCA traded down $7.22 during mid-day trading on Friday, hitting $334.26. 3,175,863 shares of the stock traded hands, compared to its average volume of 1,334,458. The business's 50-day moving average price is $373.81 and its 200 day moving average price is $345.92. The company has a market cap of $80.41 billion, a PE ratio of 14.05, a price-to-earnings-growth ratio of 1.17 and a beta of 1.47. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The business had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter in the previous year, the company earned $5.50 EPS. The business's quarterly revenue was up 6.4% compared to the same quarter last year. On average, analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. HCA Healthcare's dividend payout ratio is presently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.